A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Clinical trial NCT06722235 · RECRUITING

Trial details

NCT number: NCT06722235
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura (ITP)

Start date: 2025-02-27
Primary completion: 2028-03-16
Enrollment: 171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.